Previous 10 | Next 10 |
REDWOOD CITY, Calif. , June 25, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointments of two senior executives to the Company's leadersh...
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen’s 13F stock portfolio on a quarterly basis. It is based on Viking Global’s regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Ole Andreas Halvorsen...
REDWOOD CITY, Calif. , June 11, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the Company will be participating in the BMO 2019 Prescription...
SYDNEY , May 26, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the Company's HF10Ȓ...
REDWOOD CITY, Calif. , May 20, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that its Board of Directors has elected D. Keith Grossman , the Com...
Nevro ( NVRO ) is a successful younger ( IPO in 2014 ) company battling to establish its neuromodulation therapy to prevent a variety of chronic pain situations. It is working diligently to find itself as it faces the prospect of slowing growth. This article will describe the company's process...
Puma Biotechnology (NASDAQ: PBYI ) -35% on Q1 earnings . More news on: Puma Biotechnology, Inc., TransEnterix, Inc., Verastem, Inc., Stocks on the move, Read more ...
Nevro (NYSE: NVRO ) is down 15% premarket on light volume following its Q1 report issued after the close yesterday. Highlights: More news on: Nevro Corp., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Nevro Corp (NVRO) Q1 2019 Earnings Conference Call May 09, 2019, 16:30 ET Company Participants Juliet Cunningham - VP, IR Keith Grossman - President & CEO Andrew Galligan - CFO Conference Call Participants David Lewis - Morgan Stanley Robert Hopkins - Bank of America ...
Nevro (NYSE: NVRO ): Q1 GAAP EPS of -$1.45 misses by $0.77 . Revenue of $82.1M (-6.3% Y/Y) misses by $5.37M . Shares -10.8% . Press Release More news on: Nevro Corp., Earnings news and commentary, Healthcare stocks news,
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...